07:00 , Jul 10, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Low ERBB receptor feedback inhibitor 1 (ERRFI1; MIG6) to microRNA-200 (miR-200) ratio predicts response of cancers with wild-type epidermal growth factor receptor (EGFR) to EGFR inhibition...
07:00 , Apr 15, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Brain cancer ERBB receptor feedback inhibitor 1 (ERRFI1; MIG6) In vitro studies suggest that upregulating MIG6 could help treat glioblastoma multiforme (GBM). Deletion or...
07:00 , May 28, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Endometrial cancer ERBB receptor feedback inhibitor 1 (ERRFI1; MIG-6) Studies in mice suggest that enhancing MIG-6 activity could help treat...